Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors.

PubWeight™: 4.16‹?› | Rank: Top 1%

🔗 View Article (PMC 2967179)

Published in Surgery on October 01, 1994


T J Gayowski1, S Iwatsuki, J R Madariaga, R Selby, S Todo, W Irish, T E Starzl

Author Affiliations

1: Department of Surgery, University of Pittsburgh Medical Center, Pa.

Articles citing this

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31

Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg (2002) 8.30

Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86

Epidemiology and management of liver metastases from colorectal cancer. Ann Surg (2006) 3.37

Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer (2006) 3.26

Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92

Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg (2004) 2.65

The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg (2007) 2.23

Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22

Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer. World J Surg (2008) 2.15

Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg (1998) 2.10

Repeat hepatectomy for colorectal liver metastases. Ann Surg (1997) 1.99

Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg (1995) 1.91

Survival after hepatic resection of colorectal cancer metastases: a national experience. Cancer (2009) 1.81

Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg (2000) 1.62

Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J Surg (2007) 1.52

Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. Ann Surg (1999) 1.49

Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg (2002) 1.42

Stapler hepatectomy is a safe dissection technique: analysis of 300 patients. World J Surg (2006) 1.38

Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis. World J Surg (2004) 1.27

Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis. J Am Coll Surg (2013) 1.14

Radiofrequence ablation of liver cancers. World J Gastroenterol (2002) 1.08

Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford) (2013) 1.08

New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res (2007) 1.03

Extended resections of liver metastases from colorectal cancer. World J Surg (2007) 1.00

Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation. HPB (Oxford) (2012) 1.00

Ten-year survival after liver resection for colorectal metastases: systematic review and meta-analysis. ISRN Oncol (2011) 0.99

Practical questions in liver metastases of colorectal cancer: general principles of treatment. HPB (Oxford) (2007) 0.97

Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol (2014) 0.97

Hepatic resection for colorectal liver metastases: A cost-effectiveness analysis. Ann Surg (2000) 0.95

Surgery for colorectal liver metastases: The evolution of determining prognosis. World J Gastrointest Oncol (2013) 0.95

Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg (2002) 0.94

Management of hepatic metastases from colorectal cancer. Clin Colon Rectal Surg (2005) 0.93

Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol (2005) 0.93

Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis. Ann Surg (2003) 0.93

Treatment for colorectal liver metastases: a review. Langenbecks Arch Surg (2009) 0.93

Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases. Int J Colorectal Dis (2008) 0.93

Colorectal liver metastases. Int J Surg Oncol (2011) 0.93

Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis. Langenbecks Arch Surg (2007) 0.91

Liver resection for non-colorectal, non-carcinoid, non-sarcoma metastases: a multicenter study. PLoS One (2015) 0.91

Prognostic indicator for the resection of liver metastasis of colorectal cancer. Surg Today (2013) 0.89

Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: comparison of our scoring system to the positive number of risk factors. World J Gastroenterol (2006) 0.88

Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver. Langenbecks Arch Surg (2004) 0.87

Colorectal cancer: the role of PET/CT in recurrence. Cancer Imaging (2005) 0.84

Proposal of a new and simple staging system of colorectal liver metastasis. World J Gastroenterol (2006) 0.83

Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer. Int J Colorectal Dis (2005) 0.83

Evolution in the treatment of metastatic colorectal carcinoma of the liver. World J Gastroenterol (2006) 0.83

Results of surgical treatment for multiple (> or =5 nodules) bi-lobar hepatic metastases from colorectal cancer. Langenbecks Arch Surg (2004) 0.83

Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases. HPB (Oxford) (2009) 0.82

Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer. Clin Cancer Res (2008) 0.81

Hepatic resection in Canada: rates and geographic variation. Can J Surg (2009) 0.81

Multimodal treatment options for bilobar colorectal liver metastases. Langenbecks Arch Surg (2010) 0.80

Treatment for multiple bilobar liver metastases of colorectal cancer. Langenbecks Arch Surg (2005) 0.80

Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome. Int J Colorectal Dis (2004) 0.80

Scoring of prognostic factors that influence long-term survival in patients with hepatic metastasis of colorectal cancer. Korean J Hepatobiliary Pancreat Surg (2011) 0.79

Two hundred and forty-one consecutive liver resections: an experience from India. HPB (Oxford) (2007) 0.79

Epidural analgesia provides effective pain relief in patients undergoing open liver surgery. Br J Pain (2015) 0.79

Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg (2003) 0.79

Long-term survival after surgical resection for liver metastasis from gastric cancer: two case reports. Cancer Res Treat (2006) 0.79

Postoperative complications affect long-term survival outcomes following hepatic resection for colorectal liver metastasis. World J Surg (2015) 0.78

Prognostic significance of entrapped liver cells in hepatic metastases from colorectal cancer. Ann Surg (2000) 0.78

Prognostic impact of intrahepatic lymphatic and microvascular involvement in cases of colorectal liver metastases. Int J Colorectal Dis (2009) 0.78

Staging of resectable colorectal liver metastases. Surgery (1996) 0.78

Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment. Int J Colorectal Dis (2012) 0.78

Evolving management of colorectal cancer. World J Gastroenterol (2008) 0.78

Influence of margins on disease free survival following hepatic resection for colorectal metastasis: a meta-analysis. Indian J Surg Oncol (2012) 0.77

Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases. Radiat Oncol (2016) 0.77

Advances in therapeutics for liver metastasis from colorectal cancer. World J Gastrointest Oncol (2010) 0.77

Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver Metastases. Ann Coloproctol (2016) 0.77

Colorectal cancer - patterns of locoregional recurrence and distant metastases as demonstrated by FDG PET / CT. Indian J Radiol Imaging (2010) 0.77

Significant overexpression of DVL1 in Taiwanese colorectal cancer patients with liver metastasis. Int J Mol Sci (2013) 0.77

Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival. Int J Colorectal Dis (2013) 0.76

Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection. World J Gastroenterol (2016) 0.76

Optimal management of colorectal liver metastases in older patients: a decision analysis. HPB (Oxford) (2014) 0.75

Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases. World J Surg Oncol (2016) 0.75

Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol (2016) 0.75

Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients. Med Devices (Auckl) (2009) 0.75

Hepatic resection margin predicts survival in colorectal cancer with hepatic metastasis. Korean J Hepatobiliary Pancreat Surg (2012) 0.75

Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases. Oncol Rev (2012) 0.75

Comparison of Anatomical and Nonanatomical Hepatectomy for Colorectal Liver Metastasis: A Meta-Analysis of 5207 Patients. Sci Rep (2016) 0.75

Contemporary surgical management of synchronous colorectal liver metastases. F1000Res (2017) 0.75

Morphological response contributes to patient selection for rescue liver resection in chemotherapy patients with initially un-resectable colorectal liver metastasis. Oncol Lett (2017) 0.75

Articles cited by this

Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg (1990) 4.36

Resection of hepatic metastases from colorectal cancer. Arch Surg (1984) 4.06

Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96

Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery (1988) 3.47

Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery (1991) 3.35

Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery (1986) 3.22

The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg (1984) 3.08

Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg (1992) 2.97

Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg (1976) 2.96

Resection of liver metastases--when is it worthwhile? World J Surg (1987) 2.59

Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg (1987) 2.58

Determinants of survival in liver resection for colorectal secondaries. Br J Surg (1986) 2.58

One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg (1991) 2.55

Personal experience with 411 hepatic resections. Ann Surg (1988) 2.46

Liver resection for metastatic colorectal cancer. Surgery (1986) 1.92

Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg (1988) 1.81

The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg (1991) 1.79

Hepatic resection for colorectal secondaries. Br J Surg (1990) 1.74

Recurrence of colorectal cancer after hepatic resection. Am J Surg (1988) 1.39

The resection of hepatic metastases. Another view. Arch Surg (1989) 1.02

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48


Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med (1992) 3.42

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Changes in blood coagulation. Arch Surg (1966) 3.22

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17